Logo image of MBWS.PA

MARIE BRIZARD WINE & SPIRITS (MBWS.PA) Stock Fundamental Analysis

EPA:MBWS - Euronext Paris - Matif - FR0000060873 - Common Stock - Currency: EUR

3.01  +0.01 (+0.33%)

Fundamental Rating

4

Taking everything into account, MBWS scores 4 out of 10 in our fundamental rating. MBWS was compared to 23 industry peers in the Beverages industry. No worries on liquidiy or solvency for MBWS as it has an excellent financial health rating, but there are worries on the profitability. MBWS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MBWS had positive earnings in the past year.
In the past year MBWS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MBWS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MBWS reported negative operating cash flow in multiple years.
MBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFMBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

MBWS has a Return On Assets (3.46%) which is in line with its industry peers.
The Return On Equity of MBWS (4.52%) is worse than 82.61% of its industry peers.
With a Return On Invested Capital value of 3.24%, MBWS is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROIC 3.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBWS.PA Yearly ROA, ROE, ROICMBWS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

MBWS has a worse Profit Margin (5.12%) than 69.57% of its industry peers.
MBWS's Profit Margin has improved in the last couple of years.
The Operating Margin of MBWS (4.72%) is worse than 91.30% of its industry peers.
In the last couple of years the Operating Margin of MBWS has grown nicely.
The Gross Margin of MBWS (39.05%) is worse than 69.57% of its industry peers.
MBWS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
MBWS.PA Yearly Profit, Operating, Gross MarginsMBWS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MBWS is destroying value.
MBWS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBWS.PA Yearly Shares OutstandingMBWS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MBWS.PA Yearly Total Debt VS Total AssetsMBWS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

MBWS has an Altman-Z score of 4.23. This indicates that MBWS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.23, MBWS belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
The Debt to FCF ratio of MBWS is 0.82, which is an excellent value as it means it would take MBWS, only 0.82 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.82, MBWS belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
MBWS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, MBWS belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Altman-Z 4.23
ROIC/WACC0.41
WACC7.86%
MBWS.PA Yearly LT Debt VS Equity VS FCFMBWS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

MBWS has a Current Ratio of 2.71. This indicates that MBWS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MBWS (2.71) is better than 91.30% of its industry peers.
MBWS has a Quick Ratio of 1.84. This is a normal value and indicates that MBWS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.84, MBWS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.84
MBWS.PA Yearly Current Assets VS Current LiabilitesMBWS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

MBWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.51%, which is quite good.
Measured over the past years, MBWS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.49% on average per year.
Looking at the last year, MBWS shows a decrease in Revenue. The Revenue has decreased by -3.00% in the last year.
The Revenue has been growing slightly by 2.46% on average over the past years.
EPS 1Y (TTM)10.51%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-13.89%
Revenue 1Y (TTM)-3%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-2.1%

3.2 Future

MBWS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
MBWS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.76% yearly.
EPS Next Y-12.5%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.13%
Revenue Next 2Y2.63%
Revenue Next 3Y2.76%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MBWS.PA Yearly Revenue VS EstimatesMBWS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
MBWS.PA Yearly EPS VS EstimatesMBWS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

MBWS is valuated quite expensively with a Price/Earnings ratio of 33.44.
73.91% of the companies in the same industry are cheaper than MBWS, based on the Price/Earnings ratio.
MBWS is valuated rather expensively when we compare the Price/Earnings ratio to 27.51, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 42.16, MBWS can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MBWS is valued expensively inside the industry as 86.96% of the companies are valued cheaper.
The average S&P500 Price/Forward Earnings ratio is at 35.58. MBWS is around the same levels.
Industry RankSector Rank
PE 33.44
Fwd PE 42.16
MBWS.PA Price Earnings VS Forward Price EarningsMBWS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MBWS is valued more expensive than 86.96% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBWS indicates a slightly more expensive valuation: MBWS is more expensive than 69.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.3
EV/EBITDA 20.76
MBWS.PA Per share dataMBWS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MBWS!.
Industry RankSector Rank
Dividend Yield N/A

MARIE BRIZARD WINE & SPIRITS

EPA:MBWS (7/15/2025, 4:18:56 PM)

3.01

+0.01 (+0.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-23 2025-07-23
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap337.09M
Analysts42.22
Price Target3.37 (11.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE 33.44
Fwd PE 42.16
P/S 1.79
P/FCF 36.3
P/OCF 20.82
P/B 1.58
P/tB 2.71
EV/EBITDA 20.76
EPS(TTM)0.09
EY2.99%
EPS(NY)0.07
Fwd EY2.37%
FCF(TTM)0.08
FCFY2.75%
OCF(TTM)0.14
OCFY4.8%
SpS1.68
BVpS1.91
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROCE 3.98%
ROIC 3.24%
ROICexc 4.3%
ROICexgc 8.98%
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
FCFM 4.93%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Debt/EBITDA 0.5
Cap/Depr 144.28%
Cap/Sales 3.66%
Interest Coverage 250
Cash Conversion 118.37%
Profit Quality 96.28%
Current Ratio 2.71
Quick Ratio 1.84
Altman-Z 4.23
F-Score6
WACC7.86%
ROIC/WACC0.41
Cap/Depr(3y)199.06%
Cap/Depr(5y)172.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.51%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-13.89%
EPS Next Y-12.5%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-2.1%
Revenue Next Year2.13%
Revenue Next 2Y2.63%
Revenue Next 3Y2.76%
Revenue Next 5YN/A
EBIT growth 1Y10.35%
EBIT growth 3Y48.93%
EBIT growth 5YN/A
EBIT Next Year55.56%
EBIT Next 3Y21.14%
EBIT Next 5YN/A
FCF growth 1Y366.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y896.74%
OCF growth 3YN/A
OCF growth 5YN/A